Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer?
about
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerRecombinant TSH-stimulated, radioguided differentiated thyroid carcinoma surgery.Do negative 124I pretherapy positron emission tomography scans in patients with elevated serum thyroglobulin levels predict negative 131I posttherapy scans?Standard and emerging therapies for metastatic differentiated thyroid cancer.Novel Approaches to Thyroid Cancer Treatment and Response Assessment.Current role of radionuclide imaging in differentiated thyroid cancer.Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer.Utility of single photon emission tomography/computed tomography in characterizing an additional focus of iodine uptake in post-treatment whole body iodine scan.The role of nuclear medicine in differentiated thyroid cancer.Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology.Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients.Radioactive iodine therapy decreases recurrence in thyroid papillary microcarcinoma.Double-phase (131)I whole body scan and (131)I SPECT-CT images in patients with differentiated thyroid cancer: their effectiveness for accurate identification.Molecular imaging of advanced thyroid cancer: iodinated radiotracers and beyond.Retro-orbital metastasis from differentiated thyroid carcinoma in a radioiodine therapy-naïve patient: any lesson learned?.The comparison of (131)I whole-body scans on the third and tenth day after (131)I therapy in patients with well-differentiated thyroid cancer: preliminary report.Is postablation whole-body 131 I scintigraphy still necessary in intermediate-risk papillary thyroid cancer patients with pre-ablation stimulated thyroglobulin <1 ng/mL?Clinical applications of SPECT/CT after first I-131 ablation in patients with differentiated thyroid cancer.Rare Clinical Entity: Metastatic malignant struma ovarii diagnosed during pregnancy - Lessons for management.
P2860
Q30367068-25360B45-5CE9-4D30-B4CE-1F6BC31A573FQ33723307-6F88F4AD-C691-480F-B712-D6CB49766616Q34103801-A18948EB-4EE2-4D66-A474-4B354AA87516Q35583906-C8010B27-9AAF-4587-8D60-43B0918208DEQ36602187-64C80D63-5565-4A08-9F7D-9A4071513CB2Q36915594-6A314CB8-BB35-4994-A42D-2C9524B035BDQ37639910-BEE17196-1230-48D6-AF46-3B76E3243FFBQ37718616-F9707038-9861-4E94-B69B-0C897E15D2D3Q38027799-E1B93D3B-C129-4621-B251-6064BF01FDB0Q38571991-73A9DC01-1A06-47E7-A1DD-C627AA5FF5E4Q38879184-B356E411-ED68-452A-A229-ECD40A89E6E7Q41841525-F232177B-4024-49B2-B63A-1CF5F57ACA50Q44018498-66DA53DA-F420-40A5-85AA-BFA5F8661556Q48098904-676F5E37-573E-46CB-8C39-5A28A6EE3128Q50589811-D7551E74-B4EA-4EF6-83BF-2FCC6801D14BQ51479311-B446C1CB-DCC8-46F4-A842-445673A81197Q53059213-70E6642A-9783-463A-9B3E-09F0CA45451AQ53070847-2F392329-9C10-4E0F-8722-24B2B9EA8623Q55359345-0F7F0396-191C-4C64-862E-8A9000B04B30
P2860
Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer?
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Are posttherapy radioiodine sc ...... differentiated thyroid cancer?
@en
type
label
Are posttherapy radioiodine sc ...... differentiated thyroid cancer?
@en
prefLabel
Are posttherapy radioiodine sc ...... differentiated thyroid cancer?
@en
P2093
P356
P1433
P1476
Are posttherapy radioiodine sc ...... differentiated thyroid cancer?
@en
P2093
B P Mullan
C A Gorman
G A Wiseman
G Z Eghbali-Fatourechi
L M Thorson
V Fatourechi
P304
P356
10.1089/THY.2000.10.573
P577
2000-07-01T00:00:00Z